Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
894 results
894
Total Filings
$6934.4B
Total Raised
69
424B4 Offerings
254
ATM Programs
126
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 | RVMDW | — | — | — | ATM |
$102.74
floor
|
— | — | — | — | Cowen | Revmd may sell up to $1 billion in common stock at-the-market through TD Cowen, with last price $102.74/share; proceeds for general corporate purposes. |
| Feb 25 | LYTS | Technology | Hardware, Equipment & Parts | $746M | Public Offering |
$21.96
floor
|
$23.93 | +9.0% | — | — | Oppenheimer | # LYTS Offering Summary Lyts is raising $90 million through a common stock offering at an undisclosed price per share (last trade $21.96), with proceeds for unspecified corporate purposes. |
| Feb 25 | CISS | Industrials | Marine Shipping | $276,994 | ATM | — | $1.57 | — | — | — | — | C3IS Inc. is raising up to $98 million through at-the-market sales of common stock via Aegis Capital Corp., with proceeds for general corporate purposes. |
| Feb 25 | MCB | Financial Services | Banks - Regional | $1.0B | Public Offering |
$90.78
floor
|
$96.90 | +6.7% | — | — | UBS | Metropolitan Bank Holding Corp. is offering shares of common stock to raise $175 million for organic growth initiatives, bank investments, working capital, and general corporate purposes. |
| Feb 25 | RXRX | Healthcare | Biotechnology | $1.5B | ATM | — | $3.34 | — | — | — | Cowen | Recursion Pharmaceuticals is offering up to $300 million of Class A Common Stock at-the-market through TD Securities, with proceeds for general corporate purposes; stock trading at $3.53/share on February 24, 2026. |
| Feb 25 | HUT | Financial Services | Financial - Capital Markets | $11.1B | ATM | — | $98.33 | — | — | — | Cantor Fitzgerald, Needham, Stifel | HUT is issuing up to $1 billion in common stock through an at-the-market offering via multiple sales agents on Nasdaq and other venues, with proceeds for general corporate purposes. |
| Feb 25 | EP | Energy | Oil & Gas Exploration & Production | $103M | Public Offering |
$2.99
floor
|
$2.59 | -13.4% | 3.3M | $10M | — | Empire Petroleum Corporation is raising up to $10.0 million by selling 3,344,482 subscription rights at $2.99 per share to existing shareholders; proceeds will support general corporate purposes. |
| Feb 25 | IPWR | Industrials | Electrical Equipment & Parts | $38M | Public Offering | — | $4.41 | — | 3.5M | — | — | Ideal Power Inc. is selling 3,505,855 common shares and pre-funded warrants for 952,881 shares at undisclosed pricing; proceeds will be used for general corporate purposes. |
| Feb 25 | BRN | Energy | Oil & Gas Exploration & Production | $11M | ATM | — | $1.03 | — | — | — | — | Barnwell Industries selling up to $3.2 million of common stock at-the-market through Roth Capital Partners; proceeds for general corporate purposes, with 2.5% sales agent commission. |
| Feb 25 | LRMR | Healthcare | Biotechnology | $318M | Public Offering |
$3.69
floor
|
$3.72 | +0.8% | — | — | J.P. Morgan | Larimar Therapeutics raising $75 million through common stock and pre-funded warrant offering; proceeds for general corporate purposes and working capital. |
| Feb 25 | VGZ | Basic Materials | Gold | $245M | Secondary | — | $1.68 | — | — | — | — | Vista Gold Corp is offering $30 million of common shares at an undisclosed price per share through CIBC World Markets Inc., with proceeds for general corporate purposes. |
| Feb 25 | ZURA | Healthcare | Biotechnology | $329M | Public Offering | — | $5.06 | — | — | — | Piper Sandler | Zurify Inc. (ZURA) is offering 18.2 million Class A ordinary shares and 1.8 million pre-funded warrants at $6.25 per share/$6.249 per warrant, raising approximately $125 million gross proceeds. |
| Feb 24 | OGS | Utilities | Regulated Gas | $5.0B | Public Offering | — | $79.15 | — | — | — | BofA, J.P. Morgan, RBC Capital, Truist, Bank of America, JPMorgan | ONE Gas, Inc. selling up to $225 million in common stock through equity distribution agreement with seven managers at market prices on NYSE; proceeds for general corporate purposes. |
| Feb 24 | VIR | Healthcare | Biotechnology | $1.6B | Public Offering | — | $9.49 | — | — | — | Evercore, Barclays | Vir Biotechnology is selling $200 million of common stock at an offering price to be determined, with proceeds used for general corporate purposes. |
| Feb 24 | PVLA | Healthcare | Biotechnology | $1.8B | Public Offering | — | $149.68 | — | — | — | Cowen, Stifel, Oppenheimer | Privium Capital Inc. (PVLA) is raising $150 million through a public offering of common stock and pre-funded warrants, with proceeds to be used for general corporate purposes. |
| Feb 24 | ABTS | Financial Services | Financial - Capital Markets | $3M | Public Offering |
$3.73
floor
|
$1.19 | -68.1% | — | — | — | ABITS Group Inc. is offering up to 792,452 ordinary shares and/or Pre-Funded Warrants at $2.65 per share/$2.64999 per warrant to institutional investors, with proceeds for general corporate purposes. |
| Feb 24 | PCVX | Healthcare | Biotechnology | $8.1B | ATM |
$60.26
floor
|
$56.21 | -6.7% | — | — | — | Precivus (PCVX) may sell up to $500 million in common stock at-the-market through Leerink Partners, with proceeds for general corporate purposes, at $60.26 per share. |
| Feb 24 | ZURA | Healthcare | Biotechnology | $329M | Public Offering | — | $5.06 | — | — | — | Piper Sandler | Zurify (ZURA) is offering Class A ordinary shares and pre-funded warrants to raise capital; proceeds will fund operations, with shares priced near the $6.53 February 23, 2026 closing price. |
| Feb 24 | ATOM | Technology | Semiconductors | $208M | Public Offering |
$5.00
floor
|
$6.39 | +27.8% | — | — | — | Atomera Incorporated (ATOM) is selling 5,000,000 shares of common stock at $5.00 per share to raise $25,000,000 gross proceeds ($23,750,000 net) for general corporate purposes. |
| Feb 24 | MGEE | Utilities | Diversified Utilities | $3.1B | ATM | — | $81.17 | — | — | — | Morgan Stanley | MGE Energy, Inc. offers up to $100 million common stock through Guggenheim Securities and Morgan Stanley via at-the-market offering; proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →